Operating Lease, Right-of-Use Asset of PALISADE BIO, INC. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PALISADE BIO, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • PALISADE BIO, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PALISADE BIO, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$113,000 -100% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $22,000 -$120,000 -85% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $53,000 -$117,000 -69% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $84,000 -$114,000 -58% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $113,000 -$111,000 -50% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $142,000 -$108,000 -43% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $170,000 -$105,000 -38% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $198,000 -$102,000 -34% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $224,000 -$100,000 -31% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $250,000 -$113,000 -31% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $275,000 +$211,000 +330% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $300,000 +$191,000 +175% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $324,000 +$171,000 +112% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $363,000 +$168,000 +86% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $64,000 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $109,000 -$166,000 -60% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $153,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $195,000 30 Jun 2021 10-Q 23 Aug 2021 2021 Q2
Q4 2020 $275,000 +$70,700 +35% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 $204,300 31 Dec 2019 10-K 22 Mar 2021 2020 FY
Q3 2019 $204,300 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.